Priveq has entered an agreement to divest its holding in pharmaceuticals company Swedish Orphan International to Biovitrum today, creating Swedish Orphan Biovitrum AB.
[hr top=”20″ bottom=”20″]
[register_getpdf pdftitle=”Press release” pdflink=”https://www.priveq.se/wp-content/uploads/2016/01/Priveq-Investment-helps-create-new-specialist-pharmaceuticals-company.pdf”]
[hr top=”20″ bottom=”20″]